Quick Takeaways
- Christopher Thomas Giordano filed SCHEDULE 13D for TENAX THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (TENX).
- Disclosed ownership: 6.8%.
- Date of event: 10 Dec 2025.
Christopher Thomas Giordano - 10 Dec 2025 SCHEDULE 13D Report for TENAX THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (TENX)
- Filing Manager
- Christopher Thomas Giordano
- Reporting Manager
- Christopher Thomas Giordano
- Symbol
- TENX
- Shares outstanding
- 18,453,093 shares
- Disclosed Ownership
- 1,252,965 shares
- Ownership
- 6.8%
- Form type
- SCHEDULE 13D
- Filing time
- 10 Mar 2026, 18:02:42 UTC
- Date of event
- 10 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Christopher Thomas Giordano disclosed 6.8% ownership in TENAX THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (TENX) on 10 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Mar 2026, 18:02.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Christopher Thomas Giordano | 6.8% | 1,252,965 | 1,252,965 | 0 | /s/ Christopher Thomas Giordano | President and Chief Executive Officer | 0001871714 |